Cargando…

Fecal microbiota transplantation refurbishes the crypt-associated microbiota in ulcerative colitis

A crypt autochthonous microbial population called crypt-associated microbiota (CAM) is localized intimately with gut regenerative and immune machinery. The present report utilizes laser capture microdissection coupled with 16S amplicon sequencing to characterize the CAM in patients with ulcerative c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markandey, Manasvini, Bajaj, Aditya, Verma, Mahak, Virmani, Shubi, Singh, Mukesh Kumar, Gaur, Preksha, Das, Prasenjit, Srikanth, C.V., Makharia, Govind, Kedia, Saurabh, Ahuja, Vineet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192942/ https://www.ncbi.nlm.nih.gov/pubmed/37216124 http://dx.doi.org/10.1016/j.isci.2023.106738

Ejemplares similares

Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease
por: Markandey, Manasvini, et al.
Publicado: (2021)

Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn’s disease and intestinal tuberculosis
por: Khan, Imteyaz Ahmad, et al.
Publicado: (2021)

Development and Validation of a Smartphone Application for Telenutrition in Patients with Inflammatory Bowel Disease
por: Gupta, Arti, et al.
Publicado: (2022)

High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India
por: Kante, Bhaskar, et al.
Publicado: (2023)

Su1075: SIMILAR RISK OF INFECTION WITH SARS-COV-2 IN IMMUNOCOMPROMISED AND IMMUNOCOMPETENT PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND HEALTHY CONTROLS
por: Kante, Bhaskar, et al.
Publicado: (2022)

Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
por: Sachdeva, Karan, et al.
Publicado: (2023)

Role of Diet–Microbiome Interaction in Gastrointestinal Disorders and Strategies to Modulate Them with Microbiome-Targeted Therapies
por: Jadhav, Ajita, et al.
Publicado: (2023)

Differentiating Crohn’s disease from intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2019)

Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring
por: Kumar, Peeyush, et al.
Publicado: (2023)

Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
por: Kamat, Nagesh, et al.
Publicado: (2022)

Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2022)

Prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections in patients with inflammatory bowel disease in north India
por: Harsh, Parnita, et al.
Publicado: (2017)

High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis
por: Jain, Saransh, et al.
Publicado: (2021)

Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn’s disease
por: Vuyyuru, Sudheer K., et al.
Publicado: (2021)

Refurbishment of ROCLA
por: Latomaa, Aki Ilmari
Publicado: (2022)

Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis
por: Gupta, Akshita, et al.
Publicado: (2017)

Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study
por: Golla, Rithvik, et al.
Publicado: (2023)

CD4(+) CD25(+) FOXP3(+) T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn’s disease
por: Tiwari, Veena, et al.
Publicado: (2018)

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
por: Kumar, Suraj, et al.
Publicado: (2017)

Prevalence and Association of Mycobacterium avium subspecies paratuberculosis with Disease Course in Patients with Ulcero-Constrictive Ileocolonic Disease
por: Khan, Imteyaz Ahmad, et al.
Publicado: (2016)

Role of random biopsies in surveillance of dysplasia in ulcerative colitis patients with high risk of colorectal cancer
por: Bopanna, Sawan, et al.
Publicado: (2016)

Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial
por: Kedia, Saurabh, et al.
Publicado: (2017)

Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn’s disease: a pilot study
por: Kante, Bhaskar, et al.
Publicado: (2022)

Restaurant 1 refurbishment
por: Dolmazon, Emeline
Publicado: (2023)

A Crypt-Specific Core Microbiota Resides in the Mouse Colon
por: Pédron, Thierry, et al.
Publicado: (2012)

Left‐sided colitis and extensive colitis have similar colectomy rates after index episode of acute severe colitis: A long‐term follow‐up study
por: Jain, Saransh, et al.
Publicado: (2017)

Inflammatory and deleterious role of gut microbiota-derived trimethylamine on colon cells
por: Jalandra, Rekha, et al.
Publicado: (2023)

Impact of dietary beliefs and practices on patients with inflammatory bowel disease: An observational study from India
por: Tomar, Sanjeevani K, et al.
Publicado: (2017)

Prospective validation of CD4(+) CD25(+) FOXP3(+) T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease
por: Rampal, Ritika, et al.
Publicado: (2021)

Refurbishing Pacemakers: A Viable Approach
por: Anilkumar, R, et al.
Publicado: (2004)

Refurbishment Manual: maintenance, conversions, extensions
por: Giebeler, Georg, et al.
Publicado: (2005)

Refurbishment and extension of the terrace of Restaurant No.1
Publicado: (2009)

TCC2 Bridge Crane Refurbishment
por: Rinaldesi, Roberto
Publicado: (2022)

Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration
por: Yadav, Dawesh P., et al.
Publicado: (2017)

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
por: Agarwal, Ashish, et al.
Publicado: (2018)

VSL#3 induces and maintains short-term clinical response in patients with active microscopic colitis: a two-phase randomised clinical trial
por: Rohatgi, Sarika, et al.
Publicado: (2015)

Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion
por: Kedia, Saurabh, et al.
Publicado: (2021)

Does the road to primary prevention of inflammatory bowel disease start from childhood?
por: Kedia, Saurabh, et al.
Publicado: (2022)

Human gut microbiome: A primer for the clinician
por: Kedia, Saurabh, et al.
Publicado: (2023)

Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease
por: Tomar, Sanjeevani K, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ovks06jksidtiogqkote9odkok